Join
Live feed
·
PRReleasevia Quantisnow
Biogen Inc. logo

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIIB (Biogen Inc.) and more on Quantisnow.